- LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
- LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
- LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
- LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
- LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
- LivaNova Reports Third-Quarter 2022 Results
LivaNova PLC (LIVN:NSQ) closed at 55.28, 32.19% above the 52 week low of 41.82 set on Oct 11, 2022.
41.82Oct 11 202288.00Apr 20 2022
Markit short selling activity
|Market cap||2.96bn USD|
|EPS (TTM)||-1.81 |
Data delayed at least 15 minutes, as of Jan 27 2023 21:00 GMT.